Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Health In Tech Inc. (HIT:NASDAQ), powered by AI.
Health In Tech Inc. is currently trading at $1.07. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Health In Tech Inc. on Alpha Lenz.
Health In Tech Inc.'s P/E ratio is 46.7.
“Health In Tech Inc. trades at a P/E of 46.7 (premium valuation) with solid ROE of 8.4%. 3Y revenue CAGR of 79.4% highlights clear growth momentum.”
Ask for details →Health In Tech Inc. is a company specializing in advanced technology solutions for the healthcare sector. Its primary function is to develop innovative software platforms and digital tools designed to enhance the efficiency and effectiveness of healthcare delivery. By focusing on healthcare informatics, Health In Tech Inc. offers products that streamline data management, optimize patient care, and facilitate seamless communication within medical networks. The company's solutions are integral to supporting hospitals, clinics, and other healthcare providers in managing patient information securely and efficiently. Health In Tech Inc. plays a crucial role in the healthcare industry's digital transformation, addressing the growing demand for integrated health systems. Its products are significant in promoting interoperability and ensuring compliance with health regulations, making them indispensable for modern healthcare operations. As an influential player in the healthcare technology market, Health In Tech Inc. continues to innovate, contributing to improvements in patient outcomes and the operational success of healthcare institutions worldwide.
“Health In Tech Inc. trades at a P/E of 46.7 (premium valuation) with solid ROE of 8.4%. 3Y revenue CAGR of 79.4% highlights clear growth momentum.”
Ask for details →Health In Tech Inc. (ticker: HIT) is a company listed on NASDAQ in the Technology sector (Software - Application). It has approximately 73 employees. Market cap is $60M.
The current price is $1.07 with a P/E ratio of 46.72x and P/B of 3.49x.
ROE is 8.45% and operating margin is 4.59%. Annual revenue is $33M.